First reported at 6,885,170 shares this quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2026-09-30 | 77458163 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | New | 6,885,170 | +6,885,170 (0.0%) | 1.41% | $77,458,163 | 2026-11-16 |
Who else reported the position
59 managers reported ELECTRA THERAPEUTICS INC COM for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC This report | New | 6,885,170 | +6,885,170 | 1.41% | $77,458,163 | 1 qtr |
| Redmile Group LLC | New | 5,430,918 | +5,430,918 | 4.47% | $61,097,828 | 1 qtr |
| EQT Fund Management S a r l | New | 3,795,281 | +3,795,281 | 4.51% | $42,696,911 | 1 qtr |
| Cormorant Asset Management LP | New | 3,365,533 | +3,365,533 | 2.54% | $37,862,249 | 1 qtr |
| Nextech Invest Ltd | New | 2,636,225 | +2,636,225 | 1.33% | $29,657,531 | 1 qtr |
| Blue Owl Capital Holdings LP | New | 2,611,143 | +2,611,143 | 5.36% | $29,375,359 | 1 qtr |
| Sanofi | New | 2,461,948 | +2,461,948 | 4.4% | $27,696,915 | 1 qtr |
| JEFFERIES FINANCIAL GROUP INC | New | 2,244,333 | +2,244,333 | 0.19% | $25,248,746 | 1 qtr |
| JPMorgan Chase & Co | New | 2,095,670 | +2,095,670 | < 0.01% | $23,785,854 | 1 qtr |
| MIC Capital Management UK LLP | New | 1,977,170 | +1,977,170 | 4.8% | $22,243,163 | 1 qtr |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 16, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 6,885,170
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.